Status:
UNKNOWN
Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
ARDS
COVID
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
COVID 19 is a novel and severe disease. One of the problems is that the virus disturbs the lungs and cause water accumulation in lungs alveolus (ARDS). Today, a chest X-ray is the only practical way ...
Detailed Description
COVID 19 is a novel and severe disease. One of the problems is that the virus disturbs the lungs and cause water accumulation in lungs alveolus (ARDS). Water accumulation in pulmonary alveoli leads to...
Eligibility Criteria
Inclusion
- Covid-19 patient admitted to the infectious unit
Exclusion
- patients who do not agree to sign informed consent, or participating in other studies.
Key Trial Info
Start Date :
April 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 28 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04406493
Start Date
April 28 2020
End Date
April 28 2021
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe MC,
Hadera, Israel